Long-term effects of empagliflozin on excitation-contraction-coupling in human induced pluripotent stem cell cardiomyocytes

ABSTRACT: The SGLT2 inhibitor empagliflozin improved cardiovascular outcomes in patients with diabetes. As the cardiac mechanisms remain elusive, we investigated the long-term effects (up to 2 months) of empagliflozin on excitation-contraction (EC)-coupling in human cardiomyocytes derived from induc...

Descripción completa

Detalles Bibliográficos
Autores principales: Pabel, Steffen, Reetz, Florian, Dybkova, Nataliya, Shomroni, Orr, Salinas, Gabriela, Mustroph, Julian, Hammer, Karin P., Hasenfuss, Gerd, Hamdani, Nazha, Maier, Lars S., Streckfuss-Bömeke, Katrin, Sossalla, Samuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7679329/
https://www.ncbi.nlm.nih.gov/pubmed/33034709
http://dx.doi.org/10.1007/s00109-020-01989-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7679329/
https://www.ncbi.nlm.nih.gov/pubmed/33034709
http://dx.doi.org/10.1007/s00109-020-01989-6

Ejemplares similares